Platinum-refractory germ cell tumors: an update on current treatment options and developments
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology
Link
http://link.springer.com/article/10.1007/s00345-016-1898-z/fulltext.html
Reference67 articles.
1. Huyghe E, Plante P, Thonneau PF (2007) Testicular cancer variations in time and space in Europe. Eur Urol 51(3):621–628
2. IGCCCG (1997) International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol 15(2):594–603
3. van Dijk MR, Steyerberg EW, Habbema JD (2006) Survival of non-seminomatous germ cell cancer patients according to the IGCC classification: an update based on meta-analysis. Eur J Cancer 42(7):820–826
4. Horwich A, Shipley J, Huddart R (2006) Testicular germ-cell cancer. Lancet 367(9512):754–765
5. Beyer J, Kramar A, Mandanas R, Linkesch W, Greinix A, Droz JP, Pico JL, Diehl A, Bokemeyer C, Schmoll HJ, Nichols CR, Einhorn LH, Siegert W (1996) High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables. J Clin Oncol 14(10):2638–2645
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Clinical outcome and prognostic factors for immunotherapy-based treatments in patients with platinum-refractory germ cell tumor;International Immunopharmacology;2024-12
2. Konventionell dosierte oder Hochdosis-Salvagetherapie bei rezidivierten Hodentumoren;Aktuelle Urologie;2024-08-06
3. Potential New Therapeutic Approaches for Cisplatin-Resistant Testicular Germ Cell Tumors;Frontiers in Bioscience-Landmark;2022-08-16
4. Genetics of testicular cancer: a review;Current Opinion in Urology;2022-07-18
5. Phase II trial of nivolumab monotherapy and biomarker screening in patients with chemo‐refractory germ cell tumors;International Journal of Urology;2022-04-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3